ClinicalTrials.Veeva

Menu

Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)

Merck KGaA (EMD Serono) logo

Merck KGaA (EMD Serono)

Status and phase

Completed
Phase 3

Conditions

Non Small Cell Lung Cancer (NSCLC)

Treatments

Drug: cisplatin + vinorelbine
Drug: cetuximab + cisplatin + vinorelbine

Study type

Interventional

Funder types

Industry

Identifiers

NCT00148798
EMR 62202-046

Details and patient eligibility

About

The purpose of this trial is to investigate the efficacy of cetuximab in combination with chemotherapy in comparison to chemotherapy alone in patients with advanced non small cell lung cancer who did not received prior chemotherapy. Overall survival will be taken as primary measure of efficacy.

Enrollment

1,861 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of histologically or cytologically confirmed NSCLC, stage IIIb with documented malignant pleural effusion or stage IV
  • Immunohistochemical evidence of EGFR expression on tumor tissue
  • Presence of at least 1 bi-dimensionally measurable index lesion, whereby index lesions must not lie in an irradiated area

Exclusion criteria

  • Previous exposure to monoclonal antibodies, signal transduction inhibitors or EGFR-targeting therapy
  • Previous chemotherapy for NSCLC
  • Documented or symptomatic brain metastasis
  • Superior vena cava syndrome contra-indicating hydration
  • Previous malignancy in the last 5 years except basal cell carcinoma of the skin or pre-invasive carcinoma of the cervix

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,861 participants in 2 patient groups

Cetuximab plus chemotherapy
Experimental group
Description:
cetuximab + cisplatin + vinorelbine
Treatment:
Drug: cetuximab + cisplatin + vinorelbine
Chemotherapy alone
Active Comparator group
Description:
cisplatin + vinorelbine alone
Treatment:
Drug: cisplatin + vinorelbine

Trial contacts and locations

118

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems